Metabolon

05/07/2026

At Metabolon, connection goes beyond the lab.

Recently, a group of employees gathered for a game of Warhammer 40K, bringing strategy, creativity, and a little friendly competition to the tabletop.

Whether we’re advancing metabolomics, collaborating across teams, or commanding armies in the 41st millennium, great things happen when people come together.

Here’s to the hobbies, passions, and shared moments that make our culture uniquely Metabolon.

05/04/2026

We’re excited to be at this week!

Stop by Booth #6047 to meet the team and learn how metabolomics can help advance our understanding of retinal disease and support biomarker discovery.

04/29/2026

Combining data from genomics, transcriptomics, proteomics, and especially metabolomics, can improve how we understand biology and identify meaningful biomarkers.

Join our upcoming webinar with Dr. Vivek Das, Translational Research and Clinical Insight Leader at Novo Nordisk, who will present how integrated multiomics analysis revealed key molecular signatures linked to plaque instability in patients with carotid atherosclerosis.

In this session, you’ll learn:

• Why combining multiple omics datasets leads to deeper, more meaningful biological insights than using a single omic approach

• How metabolomics adds important functional context in multi-omics analysis

• How the DIABLO framework was used to identify cross-omic signatures linked to atherosclerotic instability

• Practical lessons from this study that can be applied to biomarker discovery, translational research, and multiomics strategies

📅 Tuesday, May 19

🕑 10 am EDT | 4 pm CEST

Register here: https://bit.ly/48uyJyX

Multiomics approaches are helping advance life sciences by providing a more complete view of biological systems and disease mechanisms.

Join us to learn how!

04/24/2026

🥼 During Lab Professionals Appreciation Week, we are proud to recognize the talented professionals behind the science at Metabolon.

Our Laboratory Operations team brings exceptional skill, consistency, and care to work that makes a meaningful impact every day. Their expertise transforms complex science into trusted results and helps drive our continued progress.

We are grateful for the focus, collaboration, and excellence they bring to every sample, every process, and every breakthrough.

Please join us in recognizing and thanking our Laboratory Operations associates for their outstanding contributions - THANK YOU, team. 👏 👏 👏

04/17/2026

Very proud to see our colleagues Dr. Adam Kennedy and Dr. Greg Michelotti leading a new Special Issue in Metabolites: https://bit.ly/4sIFZyu

“Advances in Metabolomics for Precision Medicine” explores how deeper molecular profiling can detect disease earlier, uncover new biomarkers, and better track therapeutic response across cardiometabolic, neurological, autoimmune, and more.

As the field moves toward integrating multi-omics and advanced analytics, this collection will highlight both the progress and the challenges ahead.

Worth a read if you’re interested in where precision medicine is heading.

04/16/2026

Reliability doesn’t usually get the spotlight in metabolomics, but it should.

In high-throughput LC-MS operations, small instabilities (ionization drift, calibration shifts, unplanned downtime) can quietly translate into rework, delays, and compromised data quality. Many labs see rework rates above 10% for this reason.

At Metabolon, reliability is treated as a core performance driver, not a background metric.

In this blog, Thomas Houseman, Vice President of Operations, shares how a systems-level approach to LC-MS operations (combining method harmonization, proactive QC, and volume-based preventive maintenance) helps reduce rework to ~3% while protecting uptime and throughput.

The takeaway: operational excellence isn’t just about efficiency; it’s a competitive advantage that directly impacts data quality, scalability, and client outcomes.

🔗 Read more:

Metabolon has built a performance management system that proactively controls instrument health and reduces workflow variability, lowering rework to approximately 3% while protecting uptime, throughput, and data quality

05/31/2024

🌍✨ The Metabolon team is on the move! We're thrilled to announce our participation in key events across the globe in June. Catch us in:

🇩🇪 Germany
🇺🇸 California
🇫🇷 France
🇯🇵 Japan
🇳🇱 Netherlands
🇮🇹 Italy
🇨🇭 Switzerland

We're eager to connect with industry leaders, share our latest innovations in metabolomics, and explore new collaborations. Visit our events page for more information and connect with our team to learn how deciphers thousands of discrete chemical signals from genetic and non-genetic factors to discover and reveal biological pathways. Together, let's advance the future of health through and !

📆 https://mtbln.co/qolq5e

05/30/2024

Today on , we join the global community in raising awareness about and celebrating the strength of those living with . Metabolomics research is playing a crucial role in advancing our understanding of MS, and we recently partnered with Cardiff University to advance MS research.

The collaboration aims to uncover novel and pathways associated with MS, providing deeper insights into disease mechanisms and potential therapeutic targets. Metabolomics offers a comprehensive approach to studying MS, allowing for the identification of metabolic signatures indicative of disease progression, treatment response, and patient stratification. By combining Metabolon's expertise in metabolomics with Cardiff University's MS research capabilities, this partnership holds the promise of accelerating breakthroughs in MS diagnosis, management, and treatment. Learn more here: https://bit.ly/3TlTg0i

05/30/2024

NEWS: Metabolon Announces 4-Week Turnaround Time for Commercial Projects, Enhancing Metabolomic Services for Multiomic Research: https://bit.ly/4bZWWMQ

This announcement marks a significant enhancement to our services with a new four-week project turnaround time for Global Discovery Panel projects of up to 2,000 samples, specifically tailored to meet the needs of commercial markets. This is a strategic addition to our recently launched spectral data files and bioinformatics platform offerings, reinforcing the company’s commitment to providing the highest quality and most comprehensive metabolomics solutions in the industry.

05/29/2024

Happy ! Today, we recognize the importance of and the vital role plays in advancing our understanding.

Leveraging our advanced metabolomics technology, we analyze a wide range of to uncover , , and microbial signatures relevant to conditions. Our solutions empower researchers and clinicians to better understand , optimize , and develop targeted interventions for improved digestive wellness. Explore our gastrointestinal solutions here and unlock the potential of metabolomics: https://bit.ly/3RBnxWs

05/28/2024

Check out our latest blog post "Real-Time Assessment of the Brain" which explores the transformative potential of in understanding function and diseases: https://bit.ly/3yxzwQB.

Metabolomics, which involves the comprehensive analysis of small molecules within biological systems, offers a detailed snapshot of states. This capability is particularly valuable in , where real-time monitoring of can reveal critical changes associated with conditions such as , , and . The ability to track these changes dynamically enables more precise diagnosis and better management of disease progression and therapeutic responses.

Further, the integration of metabolomics with other technologies deepens our understanding of brain function and its disorders. Ultimately, these insights could lead to the discovery of novel therapeutic targets and the development of strategies, revolutionizing the field of brain research and improving outcomes for patients with neurological conditions.

Omics technologies do not provide a real-time assessment of the signaling and metabolic pathways in the brain in response to normal and pathological stimuli.